Endopredict and mammaprint risk classification

Research article mammaprint versus endopredict: poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer.

The endopredict test provides a risk score that is either low-risk or high-risk of breast cancer recurring as distant metastasis the mammaprint test is used to predict the risk of recurrence within 10 years after diagnosis of stage i or stage ii breast cancer that is hormone-receptor-positive or hormone-receptor-negative.

Full-text paper (pdf): mammaprint versus endopredict: poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer. Comparison of risk classification between endopredict and mammaprint in er-positive/her2-negative primary invasive breast cancer. The endopredict gene-expression assay in clinical practice - performance and impact on clinical decisions ca, usa) and mammaprint® (agendia bv, amsterdam, the netherlands it provides additional prognostic information to standard pathological factors including ki67 and improves risk classification from common clinical.

Endopredict and mammaprint risk classification

endopredict and mammaprint risk classification Mammaprint versus endopredict: poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer bösl a 1 , spitzmüller a 2 , jasarevic z 1 , rauch s 3 , jäger s 4 , offner f 1.

Pdf | purpose to compare the concordance in risk classification between the endopredict and the mammaprint scores obtained for the same cancer samples on 40 estrogen-receptor positive/her2.

Shivers s, clark l, esposito n, howard n, king j, acs g, et al direct comparison of risk classification between mammaprint®, oncotype dx® and mammostrat® assays in patients with early stage breast cancer [abstract.

endopredict and mammaprint risk classification Mammaprint versus endopredict: poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer bösl a 1 , spitzmüller a 2 , jasarevic z 1 , rauch s 3 , jäger s 4 , offner f 1.
Endopredict and mammaprint risk classification
Rated 3/5 based on 28 review
Download